Andere talen Glenmark Pharmaceuticals Limited

Aandelen

GLENMARK

INE935A01035

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:47 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.079 ^INR	-0,09%		+5,16%	+26,39%

25/04	Nettowinst Glenmark Lifesciences daalt in fiscaal vierde kwartaal	MT
01/04	Glenmark Pharmaceuticals Limited kondigt bestuurswisselingen aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Glenmark Lifesciences' Net Profit Slides in Fiscal Q4	25/04
Glenmark Pharmaceuticals Limited Announces Board Changes	01/04
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
Indian shares set to open higher	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Glenmark Pharma, Pfizer Launch Atopic Dermatitis Oral Treatment in India	01/02
Indian shares set to open higher ahead of national budget	01/02
Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance 'Ichnos Glenmark Innovation'	31/01
Glenmark Pharmaceuticals Limited Partners with Pfizer to Launch Abrocitinib in India	31/01
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 for Multiple Geographies around the World	26/01
Alphamab Oncology Unit, 3D Medicines Grants Glenmark Unit License to Commercialize Sarcoma Injectable	25/01
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Pharmaceuticals Limited Launches Biosimilar of the Popular Antidiabetic Drug, Liraglutide, for the First Time in India	03/01
Glenmark Pharmaceuticals Introduces Anti-Diabetic Drug Liraglutide in India	03/01
Glenmark Pharmaceuticals : is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India	03/01
Glenmark Pharmaceuticals Swings to Loss in Fiscal Q2; Shares Slide 5%	14/11
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Anti-Psychotic Drug	07/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Glenmark Pharmaceuticals Limited

Aandelen

GLENMARK

INE935A01035

Andere talen

Filters